You have not verified your Email yet. Please verify your Email to create alerts
Verify Email
APLLTD
|
Alembic Pharma
|
Ipca Laboratories
|
JB Chem & Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
API Sector
|
|||
|
US DMF Filings
|
132.0 . | 55.0 . | n/a |
|
Pharmaceutical Sector
|
|||
|
Number of ANDA's Filed in Europe
|
21.0 | n/a | n/a |
|
Number of ANDA's Approved in Europe
|
19.0 | n/a | n/a |
|
Number of ANDA's Filed in Canada
|
21.0 | n/a | n/a |
|
Number of ANDA's Approved by Canada
|
20.0 | n/a | n/a |
|
Number of ANDA's Filed in Australia
|
17.0 | n/a | n/a |
|
Number of ANDA's Approved by Australia
|
14.0 | n/a | n/a |
|
Number of ANDA's Filed in USA
|
257.0 . | 44.0 . | 19.0 . |
|
Number of ANDA's Approved By USFDA
|
196.0 . | 18.0 . | 17.0 . |
|
Number of ANDA's Filed in Latam
|
14.0 | n/a | n/a |
|
Number of ANDA's Approved by Latam
|
4.0 | n/a | n/a |
|
Number of ANDA's Filed in South Africa
|
21.0 | n/a | n/a |
|
Number of ANDA's Approved by South Africa
|
7.0 | n/a | n/a |
|
R&D as a % of Total Sales
|
7.0 % | 2.71 % | 1.55 % |
|
Financials
|
|||
|
5 yr Average ROE
|
17.53 % | 15.9 % | 18.27 % |
|
5yr average Equity Multiplier
|
1.58 | 1.41 | 1.5 |
|
5yr Average Asset Turnover Ratio
|
0.79 | 0.81 | 0.79 |
|
5yr Avg Net Profit Margin
|
14.0 % | 13.8 % | 15.59 % |
|
Price to Book
|
4.09 | 5.58 | 10.25 |
|
P/E
|
30.97 | 60.81 | 54.19 |
|
5yr Avg Cash Conversion Cycle
|
11.4 Days | 74.74 Days | 37.72 Days |
|
Inventory Days
|
92.17 Days | 100.02 Days | 52.43 Days |
|
Days Receivable
|
59.84 Days | 55.52 Days | 63.16 Days |
|
Days Payable
|
198.11 Days | 120.62 Days | 81.2 Days |
|
5yr Average Interest Coverage Ratio
|
42.05 | 59.4 | 74.05 |
|
5yr Avg ROCE
|
19.16 % | 18.97 % | 22.31 % |
|
5yr Avg Operating Profit Margin
|
21.64 % | 22.38 % | 24.93 % |
|
5 yr average Debt to Equity
|
0.27 | 0.14 | 0.06 |
|
5yr CAGR Net Profit
|
-10.16 % | 1.13 % | 16.2 % |
|
5yr Average Return on Assets
|
10.9 % | 11.44 % | 12.35 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.61 % | 46.3 % | 53.83 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.13 % | 0.01 % | -2.08 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
3.48 % | 7.98 % | 3.6 % |
|
Alembic Pharma
|
Ipca Laboratories
|
JB Chem & Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
